Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection

Similar Items

• Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model
  by: Schleiss Mark R, et al.
  Published: (2011-03-01)
• An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model
  by: Michael P. Leviton, et al.
  Published: (2013-01-01)
• Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome
  by: Cui Xiaohong, et al.
  Published: (2008-11-01)
• Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model
  by: McGregor Alistair, et al.
  Published: (2006-03-01)
• Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection
  by: Mark R. Schleiss, et al.
  Published: (2020-09-01)